173 related articles for article (PubMed ID: 36048012)
1. Topical Ripasudil for the Treatment of Primary Corneal Endothelial Degeneration in Dogs.
Michalak SR; Kim S; Park S; Casanova MI; Bowman MAW; Ferneding M; Leonard BC; Good KL; Li JY; Thomasy SM
Transl Vis Sci Technol; 2022 Sep; 11(9):2. PubMed ID: 36048012
[TBL] [Abstract][Full Text] [Related]
2. Topical netarsudil for the treatment of primary corneal endothelial degeneration in dogs.
Casanova MI; Park S; Mayes MA; Roszak K; Ferneding M; Echeverria N; Bowman MAW; Michalak SR; Ardon M; Wong S; Le SM; Daley N; Leonard BC; Good KL; Li JY; Thomasy SM
Sci Rep; 2024 Mar; 14(1):6238. PubMed ID: 38485975
[TBL] [Abstract][Full Text] [Related]
3. Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study.
Moloney G; Garcerant Congote D; Hirnschall N; Arsiwalla T; Luiza Mylla Boso A; Toalster N; D'Souza M; Devasahayam RN
Cornea; 2021 Mar; 40(3):320-326. PubMed ID: 32740006
[TBL] [Abstract][Full Text] [Related]
4. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing.
Okumura N; Okazaki Y; Inoue R; Kakutani K; Nakano S; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1284-92. PubMed ID: 26998714
[TBL] [Abstract][Full Text] [Related]
5. Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only.
Macsai MS; Shiloach M
Cornea; 2019 May; 38(5):529-534. PubMed ID: 30720541
[TBL] [Abstract][Full Text] [Related]
6. Topical Ripasudil for the Treatment of Segmental Corneal Edema: A Case Series.
Tseng M; Feder R
Cornea; 2023 Jul; 42(7):903-907. PubMed ID: 37098107
[TBL] [Abstract][Full Text] [Related]
7. Reticular epithelial corneal edema as a novel side-effect of Rho Kinase Inhibitors: An Indian scenario.
Bhargava M; Sen S; Bhambhani V; Paul RS; Dutta C
Indian J Ophthalmol; 2022 Apr; 70(4):1163-1170. PubMed ID: 35326007
[TBL] [Abstract][Full Text] [Related]
8. Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells.
Okumura N; Okazaki Y; Inoue R; Nakano S; Fullwood NJ; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7560-7. PubMed ID: 26618648
[TBL] [Abstract][Full Text] [Related]
9. Superficial Keratectomy and Conjunctival Advancement Hood Flap (SKCAHF) for the Management of Bullous Keratopathy: Validation in Dogs With Spontaneous Disease.
Horikawa T; Thomasy SM; Stanley AA; Calderon AS; Li J; Linton LL; Murphy CJ
Cornea; 2016 Oct; 35(10):1295-304. PubMed ID: 27538190
[TBL] [Abstract][Full Text] [Related]
10. Descemetorhexis Without Grafting for Fuchs Endothelial Dystrophy-Supplementation With Topical Ripasudil.
Moloney G; Petsoglou C; Ball M; Kerdraon Y; Höllhumer R; Spiteri N; Beheregaray S; Hampson J; DʼSouza M; Devasahayam RN
Cornea; 2017 Jun; 36(6):642-648. PubMed ID: 28476048
[TBL] [Abstract][Full Text] [Related]
11. Canine endotheliitis: Clinical characteristics, advanced imaging features, and treatment.
Mayes MA; Casanova MI; Park S; Steele K; Linton L; Kim S; Good KL; Moore BA; Newbold GM; Leonard BC; Li JY; Thomasy SM
Vet Ophthalmol; 2022 May; 25 Suppl 1(Suppl 1):185-192. PubMed ID: 34971485
[TBL] [Abstract][Full Text] [Related]
12. Topical Rho-Associated Kinase Inhibitor, Y27632, Accelerates Corneal Endothelial Regeneration in a Canine Cryoinjury Model.
Miyagi H; Kim S; Li J; Murphy CJ; Thomasy SM
Cornea; 2019 Mar; 38(3):352-359. PubMed ID: 30516555
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic Characterization of Corneal Endothelial Dystrophy in German Shorthaired and Wirehaired Pointers Using In Vivo Advanced Corneal Imaging and Histopathology.
Shull OR; Reilly CM; Davis LB; Murphy CJ; Thomasy SM
Cornea; 2018 Jan; 37(1):88-94. PubMed ID: 29077583
[TBL] [Abstract][Full Text] [Related]
14. Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study.
Nakagawa H; Koizumi N; Okumura N; Suganami H; Kinoshita S
PLoS One; 2015; 10(9):e0136802. PubMed ID: 26367375
[TBL] [Abstract][Full Text] [Related]
15. The ROCK Inhibitor Ripasudil Shows an Endothelial Protective Effect in Patients With Low Corneal Endothelial Cell Density After Cataract Surgery.
Fujimoto H; Setoguchi Y; Kiryu J
Transl Vis Sci Technol; 2021 Apr; 10(4):18. PubMed ID: 34003995
[TBL] [Abstract][Full Text] [Related]
16. The Protective Effect of Rho-Associated Kinase Inhibitor Eye Drops (Ripasudil) on Corneal Endothelial Cells After Cataract Surgery: A Prospective Comparative Study.
Alkharashi M; Abusayf MM; Otaif W; Alkharashi A
Ophthalmol Ther; 2024 Jun; 13(6):1773-1781. PubMed ID: 38689101
[TBL] [Abstract][Full Text] [Related]
17. The Role of Rho Kinase Inhibitors in Corneal Diseases.
Futterknecht S; Chatzimichail E; Gugleta K; Panos GD; Gatzioufas Z
Drug Des Devel Ther; 2024; 18():97-108. PubMed ID: 38264539
[TBL] [Abstract][Full Text] [Related]
18. Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine.
Chihara E; Dimitrova G; Chihara T
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1257-1264. PubMed ID: 29520478
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of the cornea and conjunctiva of the normal laboratory beagle using time- and Fourier-domain optical coherence tomography and ultrasound pachymetry.
Strom AR; Cortés DE; Rasmussen CA; Thomasy SM; McIntyre K; Lee SF; Kass PH; Mannis MJ; Murphy CJ
Vet Ophthalmol; 2016 Jan; 19(1):50-6. PubMed ID: 25676065
[TBL] [Abstract][Full Text] [Related]
20. Effect of ripasudil on diabetic macular edema.
Minami Y; Song YS; Ishibazawa A; Omae T; Ro-Mase T; Ishiko S; Yoshida A
Sci Rep; 2019 Mar; 9(1):3703. PubMed ID: 30842496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
